Details for New Drug Application (NDA): 020323
✉ Email this page to a colleague
The generic ingredient in VIVELLE is estradiol. There are seventy-five drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the estradiol profile page.
Medical Subject Heading (MeSH) Categories for 020323
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SYSTEM;TRANSDERMAL | Strength | 0.0375MG/24HR | ||||
Approval Date: | Oct 28, 1994 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SYSTEM;TRANSDERMAL | Strength | 0.05MG/24HR | ||||
Approval Date: | Oct 28, 1994 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SYSTEM;TRANSDERMAL | Strength | 0.075MG/24HR | ||||
Approval Date: | Oct 28, 1994 | TE: | RLD: | No |
Expired US Patents for NDA 020323
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sandoz | VIVELLE | estradiol | SYSTEM;TRANSDERMAL | 020323-002 | Oct 28, 1994 | ⤷ Subscribe | ⤷ Subscribe |
Sandoz | VIVELLE | estradiol | SYSTEM;TRANSDERMAL | 020323-004 | Oct 28, 1994 | ⤷ Subscribe | ⤷ Subscribe |
Sandoz | VIVELLE | estradiol | SYSTEM;TRANSDERMAL | 020323-003 | Oct 28, 1994 | ⤷ Subscribe | ⤷ Subscribe |
Sandoz | VIVELLE | estradiol | SYSTEM;TRANSDERMAL | 020323-001 | Oct 28, 1994 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription